| 000 | 01787 a2200529 4500 | ||
|---|---|---|---|
| 005 | 20250513150855.0 | ||
| 264 | 0 | _c19981106 | |
| 008 | 199811s 0 0 eng d | ||
| 022 | _a0340-3696 | ||
| 024 | 7 |
_a10.1007/s004030050314 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aBoorsma, D M | |
| 245 | 0 | 0 |
_aChemokine IP-10 expression in cultured human keratinocytes. _h[electronic resource] |
| 260 |
_bArchives of dermatological research _cJun 1998 |
||
| 300 |
_a335-41 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 |
_aAntineoplastic Agents _xpharmacology |
| 650 | 0 | 4 | _aChemokine CXCL10 |
| 650 | 0 | 4 |
_aChemokines, CXC _xgenetics |
| 650 | 0 | 4 | _aChromatography, High Pressure Liquid |
| 650 | 0 | 4 | _aDose-Response Relationship, Drug |
| 650 | 0 | 4 | _aEnzyme-Linked Immunosorbent Assay |
| 650 | 0 | 4 |
_aGene Expression _xdrug effects |
| 650 | 0 | 4 | _aGene Expression Regulation |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aInterferon-gamma _xpharmacology |
| 650 | 0 | 4 |
_aInterleukin-1 _xpharmacology |
| 650 | 0 | 4 |
_aKeratinocytes _xcytology |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aPolymerase Chain Reaction |
| 650 | 0 | 4 |
_aRNA, Messenger _xdrug effects |
| 650 | 0 | 4 |
_aSkin _xchemistry |
| 650 | 0 | 4 |
_aTetradecanoylphorbol Acetate _xpharmacology |
| 650 | 0 | 4 | _aTime Factors |
| 650 | 0 | 4 |
_aTranscription, Genetic _xdrug effects |
| 650 | 0 | 4 |
_aTumor Necrosis Factor-alpha _xpharmacology |
| 700 | 1 | _aFlier, J | |
| 700 | 1 | _aSampat, S | |
| 700 | 1 | _aOttevanger, C | |
| 700 | 1 | _ade Haan, P | |
| 700 | 1 | _aHooft, L | |
| 700 | 1 | _aWillemze, R | |
| 700 | 1 | _aTensen, C P | |
| 700 | 1 | _aStoof, T J | |
| 773 | 0 |
_tArchives of dermatological research _gvol. 290 _gno. 6 _gp. 335-41 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1007/s004030050314 _zAvailable from publisher's website |
| 999 |
_c9670769 _d9670769 |
||